Hudson Executive Capital LP - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
Hudson Executive Capital LP ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$79,534,000
+73.5%
1,323,794
+63.4%
3.54%
+2.0%
Q3 2019$45,842,000
-49.3%
810,365
-50.1%
3.47%
-20.3%
Q2 2019$90,400,000
-38.5%
1,623,554
-44.3%
4.35%
-4.7%
Q1 2019$147,078,000
-6.0%
2,913,000
-25.0%
4.57%
+15.0%
Q4 2018$156,488,000
+132.5%
3,884,000
+300.0%
3.97%
-26.9%
Q3 2018$67,319,000
-8.4%
971,0000.0%5.44%
-66.8%
Q2 2018$73,466,000
+43.6%
971,0000.0%16.36%
+8.4%
Q1 2018$51,162,000
-1.4%
971,0000.0%15.09%
-39.4%
Q4 2017$51,871,000
-55.2%
971,000
-50.0%
24.90%
-14.5%
Q3 2017$115,820,000
-22.8%
1,942,000
+2.1%
29.13%
-15.5%
Q2 2017$149,986,000
-4.9%
1,901,2000.0%34.47%
+59.4%
Q1 2017$157,686,000
+4.5%
1,901,2000.0%21.62%
-19.4%
Q4 2016$150,842,000
+126.7%
1,901,200
+100.0%
26.82%
+127.1%
Q3 2016$66,542,000
+80.5%
950,6000.0%11.81%
-14.6%
Q2 2016$36,874,000
-11.9%
950,600
-8.1%
13.83%
+43.4%
Q1 2016$41,876,0001,034,0009.65%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 121,014$5,377,0001.78%
Smith, Graham & Co., Investment Advisors, LP 232,343$10,323,0001.28%
GLOBEFLEX CAPITAL L P 73,205$3,252,0000.79%
SummerHaven Investment Management, LLC 18,604$827,0000.56%
BRANDES INVESTMENT PARTNERS, LP 464,292$20,628,0000.50%
Capital Impact Advisors, LLC 11,728$521,0000.48%
Watershed Asset Management, L.L.C. 5,756$256,0000.32%
Foundry Partners, LLC 84,325$3,747,0000.23%
Summit Global Investments 33,738$1,499,0000.13%
SCOUT INVESTMENTS, INC. 147,034$6,533,0000.13%
View complete list of EAGLE PHARMACEUTICALS INC shareholders